您的位置: 首页 > 农业专利 > 详情页

POLYPEPTIDES TARGETING HIV FUSION
专利权人:
VIIV HEALTCARE UK (NO.5) LIMITED
发明人:
KRYSTAL, Mark, R.,WENSEL, David, L,DAVIS, Jonathan
申请号:
PH12017501914
公开号:
PH12017501914A1
申请日:
2017.10.19
申请国别(地区):
PH
年份:
2018
代理人:
摘要:
The invention is directed to polypeptides comprising a CD4 binding moiety, a gp41 binding moiety, a HIV fusion peptide inhibitor moiety and combinations thereof. More specifically, the present invention relates to polypeptides comprising a fibronectin-based scaffold domain protein that binds CD4, a fibronectin-based scaffold domain protein that binds the N17 domain of gp41, and a HIV fusion peptide inhibitor or combinations thereof. The invention also relates to the use of the innovative proteins in therapeutic applications to treat HIV.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充